South Korea: The Global Leader in Medical Aesthetics

250,000+ aesthetic procedures per 1 million population annually (highest globally). Korea sets trends that ripple through global markets within 12-24 months.

Key Korean Aesthetic Innovations Now Global

• PN/PDRN products: Korea pioneered salmon DNA in medical aesthetics; 200+ registered products
• Lyophilized skincare: Korea first commercialized ampoules at scale; now global standard
• Exosome skincare: Most developed exosome market globally
• Glass skin routines: Consumer-facing trend driving product development globally
• Combination protocols: Multi-treatment stacking pioneered in Korean clinics

Global Adoption of K-Beauty Technologies

• Skin boosters: PN/PDRN/HA intradermal injections — now mainstream in UK, UAE, SE Asia
• Lyophilized ampoules: Premium format adopted worldwide; Chinese manufacturers now producing at equivalent quality
• Exosome treatments: Korea → UAE → USA → Europe spread pattern

Implications for OEM Brands

OEM manufacturers should prioritize: PN/PDRN capability, lyophilization production lines, exosome formulation expertise, combination protocol product development.

Weitai’s Position

Deep expertise in all key K-beauty-origin technologies: PN/PDRN manufacturing, lyophilization, advanced delivery systems.